SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 06/16/2020 |
3. Issuer Name and Ticker or Trading Symbol
M&T BANK CORP [ MTB ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 2,440(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Option (right to buy) | (2) | 01/31/2028 | Common Stock | 376 | 190.78 | D | |
Option (right to buy) | (3) | 01/31/2029 | Common Stock | 505 | 164.54 | D | |
Option (right to buy) | (4) | 02/05/2030 | Common Stock | 517 | 173.04 | D |
Explanation of Responses: |
1. The reported holding includes multiple awards of restricted stock units of which 240 shares will vest on January 31, 2021; 101 shares will vest on February 5, 2021; 122 shares will vest on January 31, 2022; 101 shares will vest on February 5, 2022; and the remaining 101 shares will vest on February 5, 2023. |
2. The option granted includes a total of 376 shares. 250 of the shares are currently exercisable; and the remaining 126 shares are exercisable on or after January 31, 2021. |
3. The option granted includes a total of 505 shares. 168 of the shares are currently exercisable; an additional 168 of the shares are exercisable on or after January 31, 2021; and the remaining 169 shares are exercisable on or after January 31, 2022. |
4. The option granted includes a total of 517 shares. 172 of the shares are exercisable on or after February 5, 2021; an additional 172 of the shares are exercisable on or after February 5, 2022; and the remaining 173 shares are exercisable on or after February 5, 2023. |
Remarks: |
Exhibit List: Exhibit 24 Power of Attorney |
By: Stephen T. Wilson, Esq. (Attorney-In-Fact) | 06/25/2020 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |